Telehealth & Digital Health

Johnson & Johnson unveils promising data for its next-gen AFib tech while reinforcing the safety of its current platform in a competitive market.

Hemex Health's portable Gazelle test gets FDA Breakthrough status, paving an accelerated path for a device already changing lives in over 40 countries.

Team USA partners with smart ring maker ŌURA, leveraging cutting-edge sleep and recovery data in the high-stakes quest for Olympic and Paralympic glory.

A vague error code on millions of TRUE METRIX glucose meters led to delayed care. The company is now issuing a critical warning to prevent further harm.

A national scholarship founded by a top neurosurgeon invests in students poised to solve healthcare’s biggest challenges, addressing critical workforce shortages.

Airrosti launches REACH, a new platform combining its proven myofascial release model with digital tools to tackle the $350B MSK problem.

Chinese brand CHANDO presented a decade of research at IMCAS, revealing a new epigenetic mechanism that could revolutionize brightening for Asian skin.

After winning a major award, OnMed's tech-enabled CareStation promises to revolutionize access to care. But can this hybrid model solve a national crisis?

Major brands and tech firm Rokt join the AHA's new initiative, using AI and the power of retail to fight the leading cause of death among women.

New clinical data reveals a minimally invasive spine implant significantly cuts pain, improves function, and reduces opioid use for SI joint dysfunction.

South Korean firm Neurophet wins its third FDA clearance for an AI tool that precisely tracks Alzheimer's therapy side effects, eyeing U.S. expansion.

The biotech firm launches clinical-grade solutions at ATW 2026, promising to boost cell therapy quality, consistency, and regulatory alignment.

The lab automation firm is pivoting to intelligent systems, allowing scientists to create experiments with natural language to accelerate research.

EMD Serono and the Trump Administration launch a new program offering massive discounts on IVF drugs, bringing hope to millions of aspiring parents.

With rapid trial enrollment for a novel drug, Pulmovant offers a potential lifeline for patients with PH-ILD, a condition with few to no options.

A new 7,500-participant study will test a cfDNA-based screen to identify high-risk pregnancies months before symptoms appear, a potential paradigm shift.

Manipal's new comprehensive cancer centre in South Bengaluru integrates robotic surgery, precision radiation, and holistic support to combat rising cancer rates.

Former Senator Joe Manchin and pharma exec Heather Manchin join BlinkRx, bringing political and industry muscle to the fight for affordable medicine.

Stunning real-world data shows Iovance's Amtagvi is more effective in earlier melanoma treatment, potentially changing clinical practice and offering new hope.

New federal legislation aims to unify Canada's fragmented health records, but can it overcome deep-rooted privacy fears and technical hurdles?